Supplementation of the diet with the functional fiber PolyGlycoplex is well tolerated by healthy subjects in a clinical trial
about
Effects of PGX, a novel functional fibre, on acute and delayed postprandial glycaemia.Effect of PGX, a novel functional fibre supplement, on subjective ratings of appetite in overweight and obese women consuming a 3-day structured, low-calorie diet.Consumption of the Soluble Dietary Fibre Complex PolyGlycopleX(®) Reduces Glycaemia and Increases Satiety of a Standard Meal PostprandiallyThe safety of PolyGlycopleX (PGX) as shown in a 90-day rodent feeding study.Effect on body weight and composition in overweight/obese Australian adults over 12 months consumption of two different types of fibre supplementation in a randomized trial.Effect on Insulin, Glucose and Lipids in Overweight/Obese Australian Adults of 12 Months Consumption of Two Different Fibre Supplements in a Randomised Trial.Effects of the Soluble Fiber Complex PolyGlycopleX on Glucose Homeostasis and Body Weight in Young Zucker Diabetic RatsReduction of postprandial glycemia by the novel viscous polysaccharide PGX, in a dose-dependent manner, independent of food form.Effects of added PGX®, a novel functional fibre, on the glycaemic index of starchy foods.Safety of alginate‐konjac‐xanthan polysaccharide complex (PGX) as a novel food pursuant to Regulation (EC) No 258/97Meal replacements and fibre supplement as a strategy for weight loss. Proprietary PGX® meal replacement and PGX® fibre supplement in addition to a calorie-restricted diet to achieve weight loss in a clinical setting.Genotoxicity studies of PolyGlycopleX (PGX): a novel dietary fiber.Effects of a 3-month supplementation with a novel soluble highly viscous polysaccharide on anthropometry and blood lipids in nondieting overweight or obese adults.
P2860
Q34376490-D258EE2B-3A0B-4E42-B691-8CAD816627D3Q35825609-8759A7FB-E799-47D0-AFC3-2224CA90C534Q36941763-7DDD87E6-EE92-429C-BBD3-4F6D7286379CQ37077700-034B8712-A8FE-4FD5-B759-CFEC86C4B381Q37422122-213DFD52-E380-431A-8283-F9487D0200D5Q37673097-A698D904-5F35-44D0-9C4D-F4C308DC6073Q38335395-69804735-A94F-4049-AA54-8C1861A3B238Q42949060-48293AC2-E7F0-47D2-97C7-9B4CC6F8A2BFQ43714954-7474DF83-8E99-4D81-8D95-0159383094B4Q47159385-5E58766F-9F9B-4493-9FAB-A230DC5FFD80Q47181972-7388849D-EF2C-4DEC-AB27-B08124CA54E6Q50053912-4631AD1A-1758-4A4B-8D9D-63A909B0AC3CQ51491155-FE07A935-B68D-4EFD-9A26-1DD4874B9382
P2860
Supplementation of the diet with the functional fiber PolyGlycoplex is well tolerated by healthy subjects in a clinical trial
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Supplementation of the diet wi ...... y subjects in a clinical trial
@en
Supplementation of the diet wi ...... subjects in a clinical trial.
@nl
type
label
Supplementation of the diet wi ...... y subjects in a clinical trial
@en
Supplementation of the diet wi ...... subjects in a clinical trial.
@nl
prefLabel
Supplementation of the diet wi ...... y subjects in a clinical trial
@en
Supplementation of the diet wi ...... subjects in a clinical trial.
@nl
P2093
P2860
P356
P1433
P1476
Supplementation of the diet wi ...... y subjects in a clinical trial
@en
P2093
George A Burdock
Ioana G Carabin
Michael R Lyon
Simon Wood
Xavier Pelletier
Yves Donazzolo
P2860
P2888
P356
10.1186/1475-2891-8-9
P577
2009-02-05T00:00:00Z
P5875
P6179
1002537514